Laval, Canada

Anthony Pilorget


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Anthony Pilorget

Introduction

Anthony Pilorget is a notable inventor based in Laval, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins and polypeptides. With a total of two patents to his name, Pilorget's work has the potential to impact various medical applications.

Latest Patents

Pilorget's latest patents include the development of MAGE antigen binding proteins. These proteins are designed to bind to human MAGE-A3, and they encompass polynucleotides encoding such antigen binding proteins, along with their uses and methods of manufacture. Another significant patent is related to CASB7439 constructs, which involves compounds and methods aimed at increasing the recombinant production of CASB7439 polypeptides, as well as methods for utilizing these compounds.

Career Highlights

Anthony Pilorget is currently employed at GlaxoSmithKline Biologicals SA, where he continues to innovate and contribute to the field of biotechnology. His work at this prominent company allows him to collaborate with other experts in the industry and further his research endeavors.

Collaborations

Pilorget has worked alongside talented colleagues such as Normand Blais and Alain Bergeron. Their collaborative efforts have likely enhanced the quality and impact of their research projects.

Conclusion

In summary, Anthony Pilorget is a distinguished inventor whose work in biotechnology has led to the development of important patents. His contributions to the field, particularly in antigen binding proteins and polypeptides, showcase his innovative spirit and dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…